This content is machine translated Online training Swiss Oncology in Motion Module: COVID-19 and oncology patients There are no evidence-based recommendations for the management of tumor patients in corona crisis. The procedure is based worldwide on rational considerations and analogies. Through careful observations and exchange of… CME-Test
View Post 3 min This content is machine translated Diabetic nephropathy Inhibition of sodium-glucose transporter type 2 has a renoprotective effect Diabetic nephropathy is the most common cause of chronic kidney failure – and one of the most common consequences of diabetes mellitus. The introduction of sodium-glucose transporter type 2 (SGLT2)…
View Post 3 min This content is machine translated Diabetes Cases Multifactorial treatment of type 2 diabetes mellitus A 36-year-old obese patient wants to focus more on therapy for his type 2 diabetes mellitus and weight after his thyroidectomy. He also suffers from hypertension and dyslipidemia, which must…
View Post 4 min This content is machine translated Rheumatoid arthritis New JAK inhibitor raises hopes Treatment with disease-modifying antirheumatic drugs (DMARDs) plays an important role in modern therapeutic concepts for rheumatoid arthritis. If left untreated, joint destruction and loss of mobility are possible consequences of…
View Post 2 min This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Chronic Lymphocytic Leukemia Module The Chronic Lymphocytic Leukemia module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by PD Jeroen S. Goede, MD, Head of Hematology (Head…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Treatment Overview Prof. em. Dr. Richard Herrmann in conversation with Michael Gregor, M.D., Head of Hematology, Lucerne Cantonal Hospital Video Part 2/3: Treatment Overview CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Basics, Genetics and Guidelines Prof. em. Dr. Richard Herrmann in conversation with PD Dr. med. Jeroen S. Goede, Head of Hematology, Head of the Center for Lymphomas and Leukemias, Kantonsspital Winterthur Video Part 1/3:… CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Key Figures for Practice and Outlook for the Future Prof. em. Dr. Richard Herrmann in conversation with Prof. Dr. med. Thorsten Zenz, Senior Physician at the Center for Hematology and Oncology, University Hospital Zurich Video Part 3/3: Key figures… CME-Test
View Post 4 min This content is machine translated New treatment options for psoriasis “Real life” interim balance: PASI 100 – realistic target Research into new biologics is helping to provide treatment alternatives for moderate to severe plaque psoriasis in the event of a lack of response or loss of efficacy [1]. That…
View Post 10 min This content is machine translated Type 2 diabetes Focus Heart & Kidney: Update on the 2019 ESC and ERA-EDTA Guidelines. Type 2 diabetes is associated with an increased risk of both cardiovascular events and the development of chronic kidney disease. These aspects are therefore increasingly finding their way into current…
